Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DMD out 4.83 from 4.46, rebalancing add, will buy them back on another day
GTT out some 11.20 from 9.75 adds a few days back. love this rebalancing. I find I have most of my long holds in the lists for additions. Makes me feel like maybe I might have made some good choices
RTRX: short some 11.15 on filing Form 8-K for RETROPHIN, INC.
--------------------------------------------------------------------------------
27-Jun-2014
Other Events
Item 8.01 Other Events.
On June 27, 2014, Retrophin, Inc. (the "Company") provided preliminary single patient data from the first Pantothenate kinase-associated neurodegeneration ("PKAN") patient dosed with RE-024 under an investigator-initiated research protocol. The patient received the first dose of RE-024 on May 21, 2014. On June 5, 2014, after two weeks of treatment, the patient developed a modest elevation of liver enzymes (AST and ALT) to 1-2 times the upper limit of normal and dosing of RE-024 was temporarily discontinued. At the next follow-up visit on June 11, the patient's liver enzyme levels had trended downward and RE-024 was restarted at a reduced dose. The patient has maintained normal liver enzyme levels and remains on RE-024 as of June 25, 2014. Results for several clinical outcome measures are listed below. The Company does not believe data on a single patient can be interpreted in a meaningful fashion and is releasing this data to accommodate investor requests. Further, the results are inconclusive at this time with regard to RE-024's ability to treat patients that suffer from PKAN. Potential investors should not place undue reliance on this single patient data.
5/21/2014 5/28/2014 6/4/2014 6/11/2014 6/18/2014 6/25/12014
UPDRS1
Part 1 8/10 3/10 3/10 3/10 4/10 3/10
Part 2 36/52 26/52 26/52 27/52 26/52 26/52
Part 3 30/56 27/56 27/56 33/56 28/56 27/56
EQ-5D-3L 12/15 12/15 10/15 10/15 9/15 9/15
Barry-Albright Dystonia Scale 14/24 15/24 14/24 16/24 13/24 14/24
25 foot walk test
# of steps 25.5 19.5 17.0 16.0 16.5 15
Time in seconds 10.54 11.31 8.59 11.08 8.86 8.21
ABOUT PKAN
Pantothenate kinase-associated neurodegeneration or PKAN is the most common form of neurodegeneration with brain iron accumulation. Classic PKAN is a genetic disorder that is typically diagnosed in the first decade of life. Consequences of PKAN include dystonia, dysarthria, rigidity, retinal degeneration, and severe digestive problems. PKAN is estimated to affect 1 to 3 persons per million. PKAN typically manifests in childhood with a profound, progressive dystonia and is usually lethal. There are currently no viable treatment options for patients with PKAN.
--------------------------------------------------------------------------------
1 Unified Parkinson's Disease Rating Scale
--------------------------------------------------------------------------------
ABOUT RE-024
RE-024 is a phosphopantothenate prodrug replacement therapy with the goal of restoring the supply of this operative substrate in PKAN patients. The results discussed in this Report on Form 8-K relate to the first patient treated with RE-024 and are not indicative of future responses by this patient or by other patients.
--------------------------------------------------------------------------------
LNN: hoping to ride most of the shares down to around $74
LNN short 86.88 on miss and guidance
RRMS: 52.60 +6% on several pieces of news. In from $21's and been drawing divy all along. Current divy 1.98 with guidance increase to increase distribution 25% vs 15% previous divy growth. What a super stock this has been for me. Have held core since just after IPO, about 2.5yrs. My largest investment holding
GIMO:Gigamon’s new hire pursues growth in service provider markets across Asia Pacific
WhaTech Channel: Networking Published: Monday, 23 June 2014 16:30 Submitted by Luke Frost WhaTech Pro News from: Gigamon - Traffic Visibility Network Read: 31 times
SYDNEY, June 23, 2014 – Gigamon® (NYSE: GIMO), a leader in traffic visibility solutions with the innovative Unified Visibility Fabric™, today announced that Robert D’Amico has been appointed as Senior Director Sales – Service Provider, for Asia Pacific and Japan. He will be based in Sydney.
D’Amico’s role in leading Gigamon’s service provider business will focus on supporting existing communications service provider customers, growing sales, increasing market share and establishing a service provider partner infrastructure throughout the region.
“The prospect of building a service provider team is exciting in this high growth Asia Pacific region,” said D’Amico. “We are looking to assist our service provider customers that are experiencing visibility challenges associated with Big Data, NFV (Network Function Virtualisation) and VoLTE (Voice over Long Term Evolution). Visibility is a critical criteria of any future-looking, high performance architecture due to the increased network complexity and the volume of data.”
Gigamon’s Visibility Fabric allows customers to reduce network monitoring complexity and cost, and enables them to de-risk the rollout of projects like VoLTE and network virtualisation, while managing the explosive growth of data on their networks. Gigamon’s patented Flow Mapping® and innovative GigaSMART® solution assists operators in achieving these goals.
D’Amico sees Gigamon’s Visibility Fabric playing a key role in enhancing a wide range of solutions. For instance, Gigamon believes software-defined networking (SDN) is a powerful technology that holds promise for operational simplification, but it can leave customers with limited visibility of data in virtualised networks. This can lead to challenges in ensuring that the network is performing as desired without the proper monitoring infrastructure.
Gigamon’s Visibility Fabric architecture enables best-of-breed monitoring solutions for network performance, customer experience management, security, troubleshooting, application analysis, forensics and compliance partners to better visualise and optimise their environment.
D’Amico has more than 20 years in the high tech and telecommunications industry and joins Gigamon from his most recent role as the Service Provider, Cloud and Media Sales Manager for Australia and New Zealand at F5 Networks. Previously he worked at Cisco, McAfee, Symbol Technologies, and began his career at Telstra.
About the Visibility Fabric architecture
At Gigamon we realised that delivering the visibility essential to manage, analyse and secure the complex system that is the IT infrastructure requires a new approach. With millions of traffic flows across thousands of endpoints, visibility needs to be pervasive, intelligent and dynamic. Using our patented, unique technology, we created an innovative new approach for delivering this visibility called the Visibility Fabric architecture. This new approach is intelligent and versatile in its ability to enable visibility into the network.
About Gigamon
Gigamon provides an intelligent Visibility Fabric™ architecture for enterprises, data centres and service providers around the globe. Our technology empowers infrastructure architects, managers and operators with pervasive and dynamic intelligent visibility of traffic across both physical and virtual environments without affecting the performance or stability of the production network. Through patented technologies and centralised management, the Gigamon GigaVUE portfolio of high availability and high density products intelligently delivers the appropriate network traffic to management, analysis, compliance and security tools. With over eight years’ experience designing and building traffic visibility products in the US, Gigamon solutions are deployed globally across vertical markets including over half of the Fortune 100 and many government and federal agencies. www.gigamon.com
GIMO:Gigamon’s new hire pursues growth in service provider markets across Asia Pacific
WhaTech Channel: Networking Published: Monday, 23 June 2014 16:30 Submitted by Luke Frost WhaTech Pro News from: Gigamon - Traffic Visibility Network Read: 31 times
SYDNEY, June 23, 2014 – Gigamon® (NYSE: GIMO), a leader in traffic visibility solutions with the innovative Unified Visibility Fabric™, today announced that Robert D’Amico has been appointed as Senior Director Sales – Service Provider, for Asia Pacific and Japan. He will be based in Sydney.
D’Amico’s role in leading Gigamon’s service provider business will focus on supporting existing communications service provider customers, growing sales, increasing market share and establishing a service provider partner infrastructure throughout the region.
“The prospect of building a service provider team is exciting in this high growth Asia Pacific region,” said D’Amico. “We are looking to assist our service provider customers that are experiencing visibility challenges associated with Big Data, NFV (Network Function Virtualisation) and VoLTE (Voice over Long Term Evolution). Visibility is a critical criteria of any future-looking, high performance architecture due to the increased network complexity and the volume of data.”
Gigamon’s Visibility Fabric allows customers to reduce network monitoring complexity and cost, and enables them to de-risk the rollout of projects like VoLTE and network virtualisation, while managing the explosive growth of data on their networks. Gigamon’s patented Flow Mapping® and innovative GigaSMART® solution assists operators in achieving these goals.
D’Amico sees Gigamon’s Visibility Fabric playing a key role in enhancing a wide range of solutions. For instance, Gigamon believes software-defined networking (SDN) is a powerful technology that holds promise for operational simplification, but it can leave customers with limited visibility of data in virtualised networks. This can lead to challenges in ensuring that the network is performing as desired without the proper monitoring infrastructure.
Gigamon’s Visibility Fabric architecture enables best-of-breed monitoring solutions for network performance, customer experience management, security, troubleshooting, application analysis, forensics and compliance partners to better visualise and optimise their environment.
D’Amico has more than 20 years in the high tech and telecommunications industry and joins Gigamon from his most recent role as the Service Provider, Cloud and Media Sales Manager for Australia and New Zealand at F5 Networks. Previously he worked at Cisco, McAfee, Symbol Technologies, and began his career at Telstra.
About the Visibility Fabric architecture
At Gigamon we realised that delivering the visibility essential to manage, analyse and secure the complex system that is the IT infrastructure requires a new approach. With millions of traffic flows across thousands of endpoints, visibility needs to be pervasive, intelligent and dynamic. Using our patented, unique technology, we created an innovative new approach for delivering this visibility called the Visibility Fabric architecture. This new approach is intelligent and versatile in its ability to enable visibility into the network.
About Gigamon
Gigamon provides an intelligent Visibility Fabric™ architecture for enterprises, data centres and service providers around the globe. Our technology empowers infrastructure architects, managers and operators with pervasive and dynamic intelligent visibility of traffic across both physical and virtual environments without affecting the performance or stability of the production network. Through patented technologies and centralised management, the Gigamon GigaVUE portfolio of high availability and high density products intelligently delivers the appropriate network traffic to management, analysis, compliance and security tools. With over eight years’ experience designing and building traffic visibility products in the US, Gigamon solutions are deployed globally across vertical markets including over half of the Fortune 100 and many government and federal agencies. www.gigamon.com
thanks. I already had flash turned off on firefox, seemed to fail on IE too...but downloaded adblock plus and all my troubles went away
thanx again
NNBR new 15yr high 26.45
CMGE: small short avg 13.92
Dang sure has :D
MACK might be a good short on yesterday after close news of Sanofi pulling out and returning drug rights to MACK. Took a few shares short
GIMO has required patience, heading out for some golf so maybe it will be 20+ when i return ;)
FWIW..adblock+ took good care of the issue
thanks. pretty consistent for me. other sites I have open do not do it. so perhaps it is just the ad fetching. If I go to Home the banner adds are gone and no issues, take a page with those banner ads across the top and it rests at about 15%. right click on one of them and cpu usage just drops immediately
Been noticing ihub boards are really eating up cpu cylces. Anyone else?
Anyone else notice how ihub sites eat up CPU cycles? OR IS it just me?
GIMO about ready, needs a close $19+ and should increase the momentum
Thanx, still waiting on GIMO...Own a fair amount
CONN, let some go $48
Digirad has the Highest Future Earnings Growth in the Health Care Equipment Industry (DRAD, ABMD, CRY, ELOS, IRIX)
Written on Mon, 06/16/2014 - 7:07am
By Nick Russo
Below are the three companies in the Health Care Equipment industry with the highest future earnings growth. The growth of earnings per share (next fiscal year estimated vs. current fiscal year estimated) is important to gauge future profitability and relative value. Higher EPS growth generally justifies higher earnings multiples.
Digirad ranks highest with a future earnings growth of 133.3%. Following is ABIOMED with a future earnings growth of 94.2%. CryoLife ranks third highest with a future earnings growth of 91.5%.
Syneron Medical follows with a future earnings growth of 67.2%, and Iridex rounds out the top five with a future earnings growth of 65.0%.
SmarTrend recommended that its subscribers protect gains by selling shares of Digirad on December 5th, 2013 by issuing a Downtrend alert when the shares were trading at $3.75. Since that call, shares of Digirad have fallen 9.1%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
AI:Declares $0.875 per Share Dividend for the Second Quarter of 2014
AI:Declares $0.875 per Share Dividend for the Second Quarter of 2014
QIHU continues, may be good for several days
IBTX:52.59 from 46.20 re-entry buy
TWTR, covered for easy scalp
TWTR small short on virus/bug
http://www.geekwire.com/2014/twitter-shuts-tweetdeck-fix-nasty-bug/
AI: pattern trade buy time. Still the right time here 27.75. Divy announcment within a week. This has been a pattern trade for me each Q and usually returns 8-10% within the month. Been trading it every Q for a while. Last year announcement was on 17th June. Buy on 1st trading day of month for the Q was 24.03 close. On June 17th it found 28.83. Check out the past. Just giving a heads up so folks here can consider it.
AI: pattern trade buy time. Still the right time here 27.75. Divy announcment within a week. This has been a pattern trade for me each Q and usually returns 8-10% within the month. Last year announcement was on 17th June. Buy on 1st trading day of month for the Q was 24.03 close. On June 17th it found 28.83. Check out the past. I have posted about this pattern here in the past so just giving a heads up so folks here can consider it.
out for golf 45.50>re:CONN added trade shares 44.95
GTT 11.81 now, such a nice move on remaining shares
CONN added trade shares 44.95
IBTX: thanks Ico, they just announced acquisition of banks in your neck of the woods. As to whom the sellers were, I spoke with CFO before adding back to find out why the move down with volume. She estimated it would last about 10 days